Guiem Cerdà Pons

Guiem Cerdà Pons serves as Managing Director Europe at Ferrer since December 2022, overseeing the Prescription Medicines Business Unit and leading a team of approximately 250, with accountability for 150 million euros in revenue. Prior to this role, Guiem held various positions at Novartis from September 2013 to December 2022, including Global Marketing for Radioligand Therapy and General Manager for Ireland within the Oncology Business Unit. Additional experience includes being a Member of the Board of Directors at Real Mallorca and holding managerial roles at Deloitte Consulting and Accenture. Guiem holds advanced degrees in Engineering, Telecommunications from Universitat Politècnica de Catalunya, and has completed research in Optics/Optical Sciences at Columbia University.